Skip to content

HCW Biologics Inc.

HCWB

CIK 0001828673 · Pharmaceutical Preparations · Nasdaq

← back to feed
Revenue (TTM)
—
Q1 May 2026
Net Income (TTM)
−$5.21M
+73.5% YoY Q1 May 2026
EPS Diluted (TTM)
−$10.41
+65.7% YoY Q1 May 2026
Gross Margin
—
Q1 May 2026
Operating Margin
—
Q1 May 2026
Net Margin
—
Q1 May 2026
Free Cash Flow (TTM)
−$12.78M
Q1 May 2026
Cash
$1.23M
Q1 May 2026
Total Debt
$6.58M
Q1 May 2026
Shares Outstanding
6.73M sh
Q1 May 2026

Revenue & Net Income

EPS (Diluted)

Cash Flow

Revenue Growth (YoY)

No data available for this metric.

Balance Sheet

Cash vs Debt

Recent filings